Mayo’s Franklyn Prendergast dies at 78
Dr. Franklyn Prendergast, former Director of the Mayo Clinic Comprehensive Cancer Center, dies at 78.
Opening The Floodgates: SRC-3’s Role In Regulatory T Cell Suppression
Article recently published in Forbes explains the role of SCR-3 in regulating T cell suppression
The Legend Steve Gorlin’s Golden Rules
Podcast: The legend Steve Gorlin’s Golden Rules
SRC-3: CoRegen’s revolutionary approach to cancer
Drug Target Review’s Taylor Mixides exclusively interviewed David Lonard, PhD, Chief Scientific Officer at CoRegen and Associate Professor at Baylor University, to uncover the mechanisms of SRC-3 and why it’s key to targeting cancer – and only cancer. See full interview below or at Drug Target Review
CoRegen Appoints Edward J. Benz, M.D., to its Board of Directors
Dr. Benz, former president and chief executive officer of Dana-Farber Cancer Institute, joins CoRegen’s Board of Directors, bringing more than three decades of expertise in oncology research and cancer care